mRNA/In Vitro Transcription
- R1015 EZ Cap™ Cas9 mRNA (5-moUTP)Summary: Used with guideRNA for site-specific DNA cleavage in genome editing.
- R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)Summary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1018 EZ Cap™ Firefly Luciferase mRNASummary: Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
- R1016 EZ Cap™ EGFP mRNA (5-moUTP)Summary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1020 EZ Cap™ EPO mRNA (ψUTP)Summary: Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation.
- R1035 EZ Cap™ Fdx1 mRNASummary: Fdx1 mRNA with Cap 1 structure, providing high transcriptional efficiency
- R1036 EZ Cap™ Fdx1 mRNA (ψUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1047 EZ Cap™ mCherry mRNA (m1Ψ)Summary: mCherry mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1038 EZ Cap™ Human P16 mRNASummary: Human p16 mRNA with Cap 1 structure, providing high transcriptional efficiency